Bartlett & Co’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-300
Closed -$27K 715
2017
Q1
$27K Hold
300
﹤0.01% 509
2016
Q4
$21K Hold
300
﹤0.01% 535
2016
Q3
$24K Hold
300
﹤0.01% 529
2016
Q2
$27K Hold
300
﹤0.01% 516
2016
Q1
$25K Hold
300
﹤0.01% 515
2015
Q4
$24K Hold
300
﹤0.01% 528
2015
Q3
$21K Hold
300
﹤0.01% 539
2015
Q2
$27K Hold
300
﹤0.01% 511
2015
Q1
$30K Hold
300
﹤0.01% 500
2014
Q4
$30K Hold
300
﹤0.01% 498
2014
Q3
$29K Hold
300
﹤0.01% 503
2014
Q2
$28K Hold
300
﹤0.01% 518
2014
Q1
$25K Hold
300
﹤0.01% 513
2013
Q4
$25K Sell
300
-26
-8% -$2.12K ﹤0.01% 489
2013
Q3
$24K Hold
326
﹤0.01% 499
2013
Q2
$26K Buy
+326
New +$26.1K ﹤0.01% 485

Other funds holding MJN

Bartlett & Co's MJN Position: Q2 2017 in Review

Bartlett & Co sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 300 shares — an estimated $27K sold.

Bartlett & Co first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $30K in Q1 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Bartlett & Co reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Bartlett & Co sold 300 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $27K.
  • Bartlett & Co first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Bartlett & Co's Mead Johnson Nutrition Company position peaked at $30K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Bartlett & Co's 13F filing for Q2 2017, filed 18 Jul 2017.